Dr. Nakhoda is a clinician-scientist in the department of hematology/oncology at Fox Chase Cancer Center. She serves as steering committee member for the Leukemia & Lymphoma Society supported Philadelphia Lymphoma rounds and is a panelist on the NCCN Guidelines for Chronic Lymphocytic Leukemia. She has a research focus on improving tolerability of lymphoma and leukemia directed therapies in elderly patients and those with medical comorbidities, actively running an investigator-initiated study evaluating methods to improve methotrexate toxicity in this population. She is well suited to serve as primary investigator for this proposed project having served as local site PI for several multi-institutional investigational studies in lymphoma and with now 6 years of malignant hematology experience serving the Philadelphia area, first as hematology/oncology fellow at Temple University Hospital System and FCCC and now as an assistant professor at Fox Chase.